Number Of Genes Tested For Ovarian, Breast Cancer Has Grown, But Most Patients Don’t Undergo Testing

Cancer Therapy Advisor (3/1, Bennett) reports, “The number of genes tested for ovarian and breast cancer has grown in recent years, but most patients do not undergo testing. Thus, variant-of-unknown-significance (VUS) results are common, especially among minority populations, according to the results of a study published in the Journal of Clinical Oncology.” The study “results revealed that testing was […]

Read More